nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—Carmustine—lymphatic system cancer	0.24	0.313	CbGbCtD
Desloratadine—CYP2C19—Teniposide—lymphatic system cancer	0.175	0.228	CbGbCtD
Desloratadine—CYP2C9—Teniposide—lymphatic system cancer	0.145	0.189	CbGbCtD
Desloratadine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0987	0.128	CbGbCtD
Desloratadine—ABCB1—Vincristine—lymphatic system cancer	0.0679	0.0884	CbGbCtD
Desloratadine—ABCB1—Methotrexate—lymphatic system cancer	0.0411	0.0535	CbGbCtD
Desloratadine—Electrocardiogram abnormal—Mitoxantrone—lymphatic system cancer	0.00407	0.0176	CcSEcCtD
Desloratadine—Viral infection—Mitoxantrone—lymphatic system cancer	0.00295	0.0128	CcSEcCtD
Desloratadine—Blood bilirubin increased—Mitoxantrone—lymphatic system cancer	0.00282	0.0122	CcSEcCtD
Desloratadine—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00282	0.0122	CcSEcCtD
Desloratadine—Bronchitis—Fludarabine—lymphatic system cancer	0.0027	0.0117	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00261	0.0113	CcSEcCtD
Desloratadine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00247	0.0107	CcSEcCtD
Desloratadine—Infection—Mechlorethamine—lymphatic system cancer	0.00245	0.0106	CcSEcCtD
Desloratadine—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00244	0.0105	CcSEcCtD
Desloratadine—Epistaxis—Fludarabine—lymphatic system cancer	0.00236	0.0102	CcSEcCtD
Desloratadine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00235	0.0102	CcSEcCtD
Desloratadine—Pharyngitis—Fludarabine—lymphatic system cancer	0.00223	0.00965	CcSEcCtD
Desloratadine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00215	0.00927	CcSEcCtD
Desloratadine—Agitation—Teniposide—lymphatic system cancer	0.00205	0.00885	CcSEcCtD
Desloratadine—Oedema—Teniposide—lymphatic system cancer	0.00182	0.00786	CcSEcCtD
Desloratadine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00182	0.00785	CcSEcCtD
Desloratadine—Infection—Teniposide—lymphatic system cancer	0.00181	0.00781	CcSEcCtD
Desloratadine—Agitation—Fludarabine—lymphatic system cancer	0.0018	0.00778	CcSEcCtD
Desloratadine—Tachycardia—Teniposide—lymphatic system cancer	0.00178	0.00767	CcSEcCtD
Desloratadine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00175	0.00754	CcSEcCtD
Desloratadine—Anorexia—Teniposide—lymphatic system cancer	0.00173	0.00749	CcSEcCtD
Desloratadine—Cough—Fludarabine—lymphatic system cancer	0.00171	0.00738	CcSEcCtD
Desloratadine—Convulsion—Fludarabine—lymphatic system cancer	0.0017	0.00733	CcSEcCtD
Desloratadine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00169	0.00729	CcSEcCtD
Desloratadine—Myalgia—Fludarabine—lymphatic system cancer	0.00167	0.0072	CcSEcCtD
Desloratadine—Dyspnoea—Teniposide—lymphatic system cancer	0.00162	0.00701	CcSEcCtD
Desloratadine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0016	0.00691	CcSEcCtD
Desloratadine—Oedema—Fludarabine—lymphatic system cancer	0.0016	0.00691	CcSEcCtD
Desloratadine—Infection—Fludarabine—lymphatic system cancer	0.00159	0.00686	CcSEcCtD
Desloratadine—Decreased appetite—Teniposide—lymphatic system cancer	0.00158	0.00683	CcSEcCtD
Desloratadine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00157	0.00678	CcSEcCtD
Desloratadine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00157	0.00677	CcSEcCtD
Desloratadine—Urinary tract infection—Carmustine—lymphatic system cancer	0.00156	0.00674	CcSEcCtD
Desloratadine—Rash—Mechlorethamine—lymphatic system cancer	0.00156	0.00672	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00155	0.00672	CcSEcCtD
Desloratadine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00155	0.00671	CcSEcCtD
Desloratadine—Anorexia—Fludarabine—lymphatic system cancer	0.00152	0.00658	CcSEcCtD
Desloratadine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00149	0.00643	CcSEcCtD
Desloratadine—Nausea—Mechlorethamine—lymphatic system cancer	0.00147	0.00633	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00146	0.00629	CcSEcCtD
Desloratadine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00145	0.00626	CcSEcCtD
Desloratadine—Urticaria—Teniposide—lymphatic system cancer	0.00145	0.00624	CcSEcCtD
Desloratadine—Body temperature increased—Teniposide—lymphatic system cancer	0.00144	0.00621	CcSEcCtD
Desloratadine—Abdominal pain—Teniposide—lymphatic system cancer	0.00144	0.00621	CcSEcCtD
Desloratadine—Erythema—Bleomycin—lymphatic system cancer	0.00144	0.0062	CcSEcCtD
Desloratadine—Hallucination—Carmustine—lymphatic system cancer	0.00143	0.00619	CcSEcCtD
Desloratadine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00143	0.00616	CcSEcCtD
Desloratadine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00142	0.00611	CcSEcCtD
Desloratadine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00141	0.00608	CcSEcCtD
Desloratadine—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.0014	0.00607	CcSEcCtD
Desloratadine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00139	0.006	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00138	0.00596	CcSEcCtD
Desloratadine—Fatigue—Fludarabine—lymphatic system cancer	0.00138	0.00595	CcSEcCtD
Desloratadine—Hallucination—Vincristine—lymphatic system cancer	0.00137	0.00591	CcSEcCtD
Desloratadine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00135	0.00584	CcSEcCtD
Desloratadine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00134	0.00579	CcSEcCtD
Desloratadine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00134	0.00578	CcSEcCtD
Desloratadine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00133	0.00574	CcSEcCtD
Desloratadine—Asthenia—Teniposide—lymphatic system cancer	0.00131	0.00564	CcSEcCtD
Desloratadine—Pruritus—Teniposide—lymphatic system cancer	0.00129	0.00556	CcSEcCtD
Desloratadine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00128	0.00551	CcSEcCtD
Desloratadine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00126	0.00546	CcSEcCtD
Desloratadine—Mental disorder—Carmustine—lymphatic system cancer	0.00126	0.00545	CcSEcCtD
Desloratadine—Erythema—Carmustine—lymphatic system cancer	0.00125	0.00542	CcSEcCtD
Desloratadine—Cough—Bleomycin—lymphatic system cancer	0.00125	0.00541	CcSEcCtD
Desloratadine—Diarrhoea—Teniposide—lymphatic system cancer	0.00124	0.00538	CcSEcCtD
Desloratadine—Myalgia—Bleomycin—lymphatic system cancer	0.00122	0.00528	CcSEcCtD
Desloratadine—Mental disorder—Vincristine—lymphatic system cancer	0.0012	0.0052	CcSEcCtD
Desloratadine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00118	0.00509	CcSEcCtD
Desloratadine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00117	0.00506	CcSEcCtD
Desloratadine—Oedema—Bleomycin—lymphatic system cancer	0.00117	0.00506	CcSEcCtD
Desloratadine—Erythema—Mitoxantrone—lymphatic system cancer	0.00117	0.00503	CcSEcCtD
Desloratadine—Infection—Bleomycin—lymphatic system cancer	0.00116	0.00503	CcSEcCtD
Desloratadine—Vomiting—Teniposide—lymphatic system cancer	0.00116	0.005	CcSEcCtD
Desloratadine—Agitation—Carmustine—lymphatic system cancer	0.00115	0.00498	CcSEcCtD
Desloratadine—Asthenia—Fludarabine—lymphatic system cancer	0.00115	0.00495	CcSEcCtD
Desloratadine—Rash—Teniposide—lymphatic system cancer	0.00115	0.00495	CcSEcCtD
Desloratadine—Dermatitis—Teniposide—lymphatic system cancer	0.00115	0.00495	CcSEcCtD
Desloratadine—Headache—Teniposide—lymphatic system cancer	0.00114	0.00492	CcSEcCtD
Desloratadine—Pruritus—Fludarabine—lymphatic system cancer	0.00113	0.00489	CcSEcCtD
Desloratadine—Anorexia—Bleomycin—lymphatic system cancer	0.00112	0.00483	CcSEcCtD
Desloratadine—Agitation—Vincristine—lymphatic system cancer	0.0011	0.00475	CcSEcCtD
Desloratadine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00109	0.00472	CcSEcCtD
Desloratadine—Convulsion—Carmustine—lymphatic system cancer	0.00109	0.00469	CcSEcCtD
Desloratadine—Nausea—Teniposide—lymphatic system cancer	0.00108	0.00467	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00107	0.00461	CcSEcCtD
Desloratadine—Myalgia—Carmustine—lymphatic system cancer	0.00107	0.00461	CcSEcCtD
Desloratadine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00105	0.00451	CcSEcCtD
Desloratadine—Convulsion—Vincristine—lymphatic system cancer	0.00104	0.00448	CcSEcCtD
Desloratadine—Oedema—Carmustine—lymphatic system cancer	0.00102	0.00442	CcSEcCtD
Desloratadine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00102	0.0044	CcSEcCtD
Desloratadine—Myalgia—Vincristine—lymphatic system cancer	0.00102	0.0044	CcSEcCtD
Desloratadine—Cough—Mitoxantrone—lymphatic system cancer	0.00102	0.00439	CcSEcCtD
Desloratadine—Infection—Carmustine—lymphatic system cancer	0.00102	0.00439	CcSEcCtD
Desloratadine—Vomiting—Fludarabine—lymphatic system cancer	0.00102	0.00439	CcSEcCtD
Desloratadine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00101	0.00436	CcSEcCtD
Desloratadine—Rash—Fludarabine—lymphatic system cancer	0.00101	0.00435	CcSEcCtD
Desloratadine—Dermatitis—Fludarabine—lymphatic system cancer	0.00101	0.00435	CcSEcCtD
Desloratadine—Headache—Fludarabine—lymphatic system cancer	0.001	0.00433	CcSEcCtD
Desloratadine—Tachycardia—Carmustine—lymphatic system cancer	0.000999	0.00431	CcSEcCtD
Desloratadine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000992	0.00429	CcSEcCtD
Desloratadine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000977	0.00422	CcSEcCtD
Desloratadine—Oedema—Vincristine—lymphatic system cancer	0.000977	0.00422	CcSEcCtD
Desloratadine—Anorexia—Carmustine—lymphatic system cancer	0.000975	0.00421	CcSEcCtD
Desloratadine—Infection—Vincristine—lymphatic system cancer	0.00097	0.00419	CcSEcCtD
Desloratadine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000958	0.00414	CcSEcCtD
Desloratadine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000951	0.00411	CcSEcCtD
Desloratadine—Oedema—Mitoxantrone—lymphatic system cancer	0.000951	0.00411	CcSEcCtD
Desloratadine—Nausea—Fludarabine—lymphatic system cancer	0.00095	0.0041	CcSEcCtD
Desloratadine—Infection—Mitoxantrone—lymphatic system cancer	0.000945	0.00408	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000932	0.00403	CcSEcCtD
Desloratadine—Urticaria—Bleomycin—lymphatic system cancer	0.000931	0.00402	CcSEcCtD
Desloratadine—Anorexia—Vincristine—lymphatic system cancer	0.000931	0.00402	CcSEcCtD
Desloratadine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000928	0.00401	CcSEcCtD
Desloratadine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000927	0.004	CcSEcCtD
Desloratadine—Insomnia—Carmustine—lymphatic system cancer	0.000926	0.004	CcSEcCtD
Desloratadine—Irritability—Methotrexate—lymphatic system cancer	0.00092	0.00398	CcSEcCtD
Desloratadine—Mood swings—Methotrexate—lymphatic system cancer	0.000914	0.00395	CcSEcCtD
Desloratadine—Dyspnoea—Carmustine—lymphatic system cancer	0.000912	0.00394	CcSEcCtD
Desloratadine—Somnolence—Carmustine—lymphatic system cancer	0.00091	0.00393	CcSEcCtD
Desloratadine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000907	0.00392	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00089	0.00384	CcSEcCtD
Desloratadine—Decreased appetite—Carmustine—lymphatic system cancer	0.00089	0.00384	CcSEcCtD
Desloratadine—Insomnia—Vincristine—lymphatic system cancer	0.000884	0.00382	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000883	0.00382	CcSEcCtD
Desloratadine—Breast disorder—Methotrexate—lymphatic system cancer	0.000871	0.00376	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000867	0.00374	CcSEcCtD
Desloratadine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000864	0.00373	CcSEcCtD
Desloratadine—Decreased appetite—Vincristine—lymphatic system cancer	0.000849	0.00367	CcSEcCtD
Desloratadine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000848	0.00366	CcSEcCtD
Desloratadine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000846	0.00365	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000843	0.00364	CcSEcCtD
Desloratadine—Fatigue—Vincristine—lymphatic system cancer	0.000842	0.00364	CcSEcCtD
Desloratadine—Asthenia—Bleomycin—lymphatic system cancer	0.000841	0.00363	CcSEcCtD
Desloratadine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000837	0.00362	CcSEcCtD
Desloratadine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000837	0.00361	CcSEcCtD
Desloratadine—Pruritus—Bleomycin—lymphatic system cancer	0.000829	0.00358	CcSEcCtD
Desloratadine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000827	0.00357	CcSEcCtD
Desloratadine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00082	0.00354	CcSEcCtD
Desloratadine—Abdominal pain—Carmustine—lymphatic system cancer	0.000809	0.00349	CcSEcCtD
Desloratadine—Body temperature increased—Carmustine—lymphatic system cancer	0.000809	0.00349	CcSEcCtD
Desloratadine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000799	0.00345	CcSEcCtD
Desloratadine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000778	0.00336	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000775	0.00335	CcSEcCtD
Desloratadine—Body temperature increased—Vincristine—lymphatic system cancer	0.000772	0.00334	CcSEcCtD
Desloratadine—Abdominal pain—Vincristine—lymphatic system cancer	0.000772	0.00334	CcSEcCtD
Desloratadine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000756	0.00326	CcSEcCtD
Desloratadine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000754	0.00326	CcSEcCtD
Desloratadine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000752	0.00325	CcSEcCtD
Desloratadine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000752	0.00325	CcSEcCtD
Desloratadine—Vomiting—Bleomycin—lymphatic system cancer	0.000745	0.00322	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000743	0.00321	CcSEcCtD
Desloratadine—Infestation—Methotrexate—lymphatic system cancer	0.000743	0.00321	CcSEcCtD
Desloratadine—Rash—Bleomycin—lymphatic system cancer	0.000739	0.00319	CcSEcCtD
Desloratadine—Dermatitis—Bleomycin—lymphatic system cancer	0.000738	0.00319	CcSEcCtD
Desloratadine—Asthenia—Carmustine—lymphatic system cancer	0.000734	0.00317	CcSEcCtD
Desloratadine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00072	0.00311	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000703	0.00304	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—lymphatic system cancer	0.000701	0.00303	CcSEcCtD
Desloratadine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000701	0.00303	CcSEcCtD
Desloratadine—Asthenia—Vincristine—lymphatic system cancer	0.000701	0.00303	CcSEcCtD
Desloratadine—Diarrhoea—Carmustine—lymphatic system cancer	0.0007	0.00302	CcSEcCtD
Desloratadine—Nausea—Bleomycin—lymphatic system cancer	0.000696	0.00301	CcSEcCtD
Desloratadine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000683	0.00295	CcSEcCtD
Desloratadine—Dizziness—Carmustine—lymphatic system cancer	0.000677	0.00292	CcSEcCtD
Desloratadine—Diarrhoea—Vincristine—lymphatic system cancer	0.000668	0.00289	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—lymphatic system cancer	0.000667	0.00288	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000662	0.00286	CcSEcCtD
Desloratadine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000651	0.00281	CcSEcCtD
Desloratadine—Vomiting—Carmustine—lymphatic system cancer	0.000651	0.00281	CcSEcCtD
Desloratadine—Dizziness—Vincristine—lymphatic system cancer	0.000646	0.00279	CcSEcCtD
Desloratadine—Rash—Carmustine—lymphatic system cancer	0.000645	0.00279	CcSEcCtD
Desloratadine—Dermatitis—Carmustine—lymphatic system cancer	0.000645	0.00278	CcSEcCtD
Desloratadine—Headache—Carmustine—lymphatic system cancer	0.000641	0.00277	CcSEcCtD
Desloratadine—Vomiting—Vincristine—lymphatic system cancer	0.000621	0.00268	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000619	0.00267	CcSEcCtD
Desloratadine—Rash—Vincristine—lymphatic system cancer	0.000616	0.00266	CcSEcCtD
Desloratadine—Dermatitis—Vincristine—lymphatic system cancer	0.000615	0.00266	CcSEcCtD
Desloratadine—Headache—Vincristine—lymphatic system cancer	0.000612	0.00264	CcSEcCtD
Desloratadine—Nausea—Carmustine—lymphatic system cancer	0.000608	0.00263	CcSEcCtD
Desloratadine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000605	0.00261	CcSEcCtD
Desloratadine—Rash—Mitoxantrone—lymphatic system cancer	0.0006	0.00259	CcSEcCtD
Desloratadine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000599	0.00259	CcSEcCtD
Desloratadine—Headache—Mitoxantrone—lymphatic system cancer	0.000596	0.00257	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—lymphatic system cancer	0.000584	0.00252	CcSEcCtD
Desloratadine—Erythema—Methotrexate—lymphatic system cancer	0.000581	0.00251	CcSEcCtD
Desloratadine—Nausea—Vincristine—lymphatic system cancer	0.00058	0.00251	CcSEcCtD
Desloratadine—Nausea—Mitoxantrone—lymphatic system cancer	0.000565	0.00244	CcSEcCtD
Desloratadine—Cough—Methotrexate—lymphatic system cancer	0.000507	0.00219	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—lymphatic system cancer	0.000503	0.00217	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—lymphatic system cancer	0.000494	0.00214	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000474	0.00205	CcSEcCtD
Desloratadine—Infection—Methotrexate—lymphatic system cancer	0.000471	0.00203	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000465	0.00201	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—lymphatic system cancer	0.000452	0.00195	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000432	0.00187	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—lymphatic system cancer	0.000429	0.00185	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000423	0.00183	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—lymphatic system cancer	0.000421	0.00182	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000417	0.0018	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000412	0.00178	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000409	0.00177	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—lymphatic system cancer	0.000409	0.00176	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000388	0.00167	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—lymphatic system cancer	0.000377	0.00163	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000375	0.00162	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000375	0.00162	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000349	0.00151	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—lymphatic system cancer	0.00034	0.00147	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—lymphatic system cancer	0.000335	0.00145	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000324	0.0014	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—lymphatic system cancer	0.000313	0.00135	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—lymphatic system cancer	0.000301	0.0013	CcSEcCtD
Desloratadine—Rash—Methotrexate—lymphatic system cancer	0.000299	0.00129	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—lymphatic system cancer	0.000299	0.00129	CcSEcCtD
Desloratadine—Headache—Methotrexate—lymphatic system cancer	0.000297	0.00128	CcSEcCtD
Desloratadine—Nausea—Methotrexate—lymphatic system cancer	0.000282	0.00122	CcSEcCtD
